Free Trial

Merck KGaA (OTCMKTS:MKGAF) Shares Cross Above Fifty Day Moving Average - Should You Sell?

Merck KGaA logo with Medical background

Merck KGaA (OTCMKTS:MKGAF - Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $133.99 and traded as high as $134.99. Merck KGaA shares last traded at $134.76, with a volume of 163 shares trading hands.

Merck KGaA Price Performance

The company has a market cap of $17.42 billion, a PE ratio of 20.57 and a beta of 0.96. The firm's 50-day moving average is $133.99 and its 200-day moving average is $139.63. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Recommended Stories

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines